We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $116B
1-Year Est. Return 61.47%
This Fund
S&P 500
This Quarter Est. Return
-14.67%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$39.6B
AUM Growth
-$8.6B
Cap. Flow
-$515M
Cap. Flow %
-1.3%
Top 10 Hldgs %
21.58%
Holding
2,991
New
339
Increased
842
Reduced
1,284
Closed
225

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$196M
2
ORLY icon
O'Reilly Automotive
ORLY
+$193M
3
ROST icon
Ross Stores
ROST
+$180M
4
LLY icon
Eli Lilly
LLY
+$164M
5
CDW icon
CDW
CDW
+$153M

Sector Composition

Rank Sector Weight
1 Technology 24.13%
2 Healthcare 14.61%
3 Financials 11.07%
4 Consumer Discretionary 10.65%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTRA
2001
DELISTED
Proterra Inc. Common Stock
PTRA
$384K ﹤0.01%
+82,723
New +$506K
TSP
2002
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$383K ﹤0.01%
+52,971
New +$482K
CCC
2003
CCC Intelligent Solutions
CCC
$4.19B
$382K ﹤0.01%
+41,475
New +$381K
FF icon
2004
Future Fuel
FF
$249M
$380K ﹤0.01%
52,182
+39,602
+315% +$333K
FFIC
2005
DELISTED
Flushing Financial
FFIC
$380K ﹤0.01%
17,845
IRBT
2006
DELISTED
iRobot
IRBT
$379K ﹤0.01%
10,321
-365
-3% -$17.6K
WOW
2007
DELISTED
WideOpenWest
WOW
$379K ﹤0.01%
20,826
-1,316
-6% -$26.5K
MODN
2008
DELISTED
MODEL N, INC.
MODN
$379K ﹤0.01%
14,809
BBIO icon
2009
BridgeBio Pharma
BBIO
$15.9B
$378K ﹤0.01%
41,578
MRTX
2010
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$378K ﹤0.01%
5,633
-12,298
-69% -$782K
DNUT icon
2011
Krispy Kreme
DNUT
$569M
$377K ﹤0.01%
+27,751
New +$383K
ERII icon
2012
Energy Recovery
ERII
$397M
$377K ﹤0.01%
19,424
+2,760
+17% +$53.5K
GABC icon
2013
German American Bancorp
GABC
$1.91B
$376K ﹤0.01%
11,002
CCJ icon
2014
Cameco
CCJ
$42.6B
$375K ﹤0.01%
17,897
-193
-1% -$4.87K
PRTA icon
2015
Prothena Corp
PRTA
$466M
$375K ﹤0.01%
13,795
-500
-3% -$14.6K
TVRD
2016
Tvardi Therapeutics
TVRD
$22.1M
$375K ﹤0.01%
1,140
RVNC
2017
DELISTED
Revance Therapeutics, Inc.
RVNC
$375K ﹤0.01%
27,154
-591
-2% -$9.1K
VECO icon
2018
Veeco
VECO
$3.26B
$374K ﹤0.01%
19,273
-646
-3% -$14.3K
DNA icon
2019
Ginkgo Bioworks
DNA
$488M
$373K ﹤0.01%
+3,917
New +$478K
AMWL icon
2020
American Well
AMWL
$215M
$372K ﹤0.01%
4,309
+684
+19% +$51K
ENOV icon
2021
Enovis
ENOV
$1.42B
$372K ﹤0.01%
6,761
-45,928
-87% -$2.96M
EVC icon
2022
Entravision Communication
EVC
$820M
$371K ﹤0.01%
81,349
+4,184
+5% +$21.5K
PFC
2023
DELISTED
Premier Financial Corp. Common Stock
PFC
$371K ﹤0.01%
14,643
FRG
2024
DELISTED
Franchise Group, Inc.
FRG
$371K ﹤0.01%
10,585
-570
-5% -$22K
CAL icon
2025
Caleres
CAL
$455M
$370K ﹤0.01%
14,106
-867
-6% -$21.5K

Similar funds

VOYA Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, VOYA Investment Management held 2,991 positions worth $39.6B, down 18% from $48.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

VOYA Investment Management's Q2 2022 filing shows 339 new, 842 increased, 1,284 reduced and 225 closed positions. Its largest new stake was iShares MSCI Japan ETF: 5,498,157 shares worth $290M. The largest sale was Zebra Technologies, an estimated $196M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • VOYA Investment Management's largest Q2 2022 buy was iShares MSCI Japan ETF: 5,498,157 shares worth $290M.
  • VOYA Investment Management added most to Visa in Q2 2022, an estimated $356M increase.
  • VOYA Investment Management's biggest Q2 2022 reduction was Zebra Technologies, cutting an estimated $196M.
  • VOYA Investment Management fully exited Canada Goose Holdings in Q2 2022, selling an estimated $11M.
  • VOYA Investment Management's ten largest holdings make up 22% of its $39.6B portfolio in Q2 2022.
  • VOYA Investment Management opened 339 new positions and closed 225 in Q2 2022.
  • VOYA Investment Management's portfolio value fell 18% quarter-over-quarter to $39.6B.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.